Alnylam Pharmaceuticals
Alnylam Pharmaceuticals
alnylam.com

Locations

Cambridge, MA, USA · Cambridge, MA, USA

industry

Biotechnology · DeepTech · Health

Size

1001-5000 employees

Stage

Other

founded in

2002

Alnylam (Nasdaq: ALNY) is the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare genetic, cardio-metabolic, hepatic infectious, and central nervous system (CNS)/ocular diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach for the treatment of a wide range of severe and debilitating diseases.

Something looks off?
Open jobs at Alnylam Pharmaceuticals
Powered by Getro